ERFSF
Price
$74.77
Change
+$0.37 (+0.50%)
Updated
Sep 5 closing price
Capitalization
13.22B
RGEN
Price
$124.56
Change
+$3.98 (+3.30%)
Updated
Sep 5 closing price
Capitalization
7.01B
58 days until earnings call
Interact to see
Advertisement

ERFSF vs RGEN

Header iconERFSF vs RGEN Comparison
Open Charts ERFSF vs RGENBanner chart's image
Eurofins Scientific Nante
Price$74.77
Change+$0.37 (+0.50%)
Volume$823
Capitalization13.22B
Repligen
Price$124.56
Change+$3.98 (+3.30%)
Volume$1.04M
Capitalization7.01B
ERFSF vs RGEN Comparison Chart in %
Loading...
ERFSF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RGEN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ERFSF vs. RGEN commentary
Sep 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ERFSF is a Hold and RGEN is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 07, 2025
Stock price -- (ERFSF: $74.77 vs. RGEN: $124.56)
Brand notoriety: ERFSF and RGEN are both not notable
ERFSF represents the Medical Specialties, while RGEN is part of the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: ERFSF: 69% vs. RGEN: 133%
Market capitalization -- ERFSF: $13.22B vs. RGEN: $7.01B
ERFSF [@Medical Specialties] is valued at $13.22B. RGEN’s [@Pharmaceuticals: Other] market capitalization is $7.01B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $167.36B to $0. The average market capitalization across the [@Medical Specialties] industry is $10.69B. The average market capitalization across the [@Pharmaceuticals: Other] industry is $11.09B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ERFSF’s FA Score shows that 1 FA rating(s) are green whileRGEN’s FA Score has 1 green FA rating(s).

  • ERFSF’s FA Score: 1 green, 4 red.
  • RGEN’s FA Score: 1 green, 4 red.
According to our system of comparison, ERFSF is a better buy in the long-term than RGEN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ERFSF’s TA Score shows that 3 TA indicator(s) are bullish while RGEN’s TA Score has 6 bullish TA indicator(s).

  • ERFSF’s TA Score: 3 bullish, 5 bearish.
  • RGEN’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, RGEN is a better buy in the short-term than ERFSF.

Price Growth

ERFSF (@Medical Specialties) experienced а -1.03% price change this week, while RGEN (@Pharmaceuticals: Other) price change was +1.83% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +1.01%. For the same industry, the average monthly price growth was +8.25%, and the average quarterly price growth was +13.64%.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -1.24%. For the same industry, the average monthly price growth was +7.04%, and the average quarterly price growth was +16.54%.

Reported Earning Dates

RGEN is expected to report earnings on Nov 04, 2025.

Industries' Descriptions

@Medical Specialties (+1.01% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

@Pharmaceuticals: Other (-1.24% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ERFSF($13.2B) has a higher market cap than RGEN($7.01B). RGEN has higher P/E ratio than ERFSF: RGEN (511.11) vs ERFSF (28.25). ERFSF YTD gains are higher at: 42.538 vs. RGEN (-13.464). ERFSF has higher annual earnings (EBITDA): 1.46B vs. RGEN (99.5M). ERFSF has more cash in the bank: 753M vs. RGEN (709M). RGEN has less debt than ERFSF: RGEN (686M) vs ERFSF (4.11B). ERFSF has higher revenues than RGEN: ERFSF (7.14B) vs RGEN (674M).
ERFSFRGENERFSF / RGEN
Capitalization13.2B7.01B188%
EBITDA1.46B99.5M1,471%
Gain YTD42.538-13.464-316%
P/E Ratio28.25511.116%
Revenue7.14B674M1,060%
Total Cash753M709M106%
Total Debt4.11B686M600%
FUNDAMENTALS RATINGS
ERFSF vs RGEN: Fundamental Ratings
ERFSF
RGEN
OUTLOOK RATING
1..100
5068
VALUATION
overvalued / fair valued / undervalued
1..100
10
Undervalued
95
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9491
PRICE GROWTH RATING
1..100
4760
P/E GROWTH RATING
1..100
482
SEASONALITY SCORE
1..100
8550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ERFSF's Valuation (10) in the null industry is significantly better than the same rating for RGEN (95) in the Biotechnology industry. This means that ERFSF’s stock grew significantly faster than RGEN’s over the last 12 months.

ERFSF's Profit vs Risk Rating (100) in the null industry is in the same range as RGEN (100) in the Biotechnology industry. This means that ERFSF’s stock grew similarly to RGEN’s over the last 12 months.

RGEN's SMR Rating (91) in the Biotechnology industry is in the same range as ERFSF (94) in the null industry. This means that RGEN’s stock grew similarly to ERFSF’s over the last 12 months.

ERFSF's Price Growth Rating (47) in the null industry is in the same range as RGEN (60) in the Biotechnology industry. This means that ERFSF’s stock grew similarly to RGEN’s over the last 12 months.

RGEN's P/E Growth Rating (2) in the Biotechnology industry is somewhat better than the same rating for ERFSF (48) in the null industry. This means that RGEN’s stock grew somewhat faster than ERFSF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ERFSFRGEN
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 3 days ago
67%
Bullish Trend 3 days ago
82%
Momentum
ODDS (%)
Bearish Trend 3 days ago
71%
Bullish Trend 3 days ago
71%
MACD
ODDS (%)
Bearish Trend 3 days ago
73%
Bullish Trend 3 days ago
85%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
64%
Bullish Trend 3 days ago
74%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
64%
Bullish Trend 3 days ago
72%
Advances
ODDS (%)
Bullish Trend 3 days ago
71%
Bullish Trend 3 days ago
75%
Declines
ODDS (%)
Bearish Trend 6 days ago
62%
Bearish Trend 5 days ago
81%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
77%
Bullish Trend 3 days ago
75%
Aroon
ODDS (%)
Bullish Trend 3 days ago
73%
Bearish Trend 3 days ago
79%
View a ticker or compare two or three
Interact to see
Advertisement
ERFSF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RGEN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
EUGCX24.680.14
+0.57%
Morgan Stanley Europe Opportunity L
FSTSX20.06N/A
N/A
Fidelity Series International Sm Cap
SBRVX16.11N/A
N/A
Segall Bryant & Hamill Sm Cp Val Ret
FEPUX61.85N/A
N/A
American Funds EUPAC 529-F-3
HMVUX16.35N/A
N/A
Hartford MidCap Value R6

ERFSF and

Correlation & Price change

A.I.dvisor tells us that ERFSF and RGEN have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ERFSF and RGEN's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ERFSF
1D Price
Change %
ERFSF100%
+0.50%
RGEN - ERFSF
26%
Poorly correlated
+3.30%
KIDS - ERFSF
22%
Poorly correlated
+0.97%
SAUHY - ERFSF
22%
Poorly correlated
+0.51%
BFLY - ERFSF
22%
Poorly correlated
+1.96%
SOAGY - ERFSF
22%
Poorly correlated
+3.02%
More

RGEN and

Correlation & Price change

A.I.dvisor indicates that over the last year, RGEN has been closely correlated with DHR. These tickers have moved in lockstep 67% of the time. This A.I.-generated data suggests there is a high statistical probability that if RGEN jumps, then DHR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RGEN
1D Price
Change %
RGEN100%
+3.30%
DHR - RGEN
67%
Closely correlated
+0.59%
A - RGEN
65%
Loosely correlated
+0.21%
BIO - RGEN
60%
Loosely correlated
+2.07%
MTD - RGEN
59%
Loosely correlated
+1.39%
TMO - RGEN
58%
Loosely correlated
+0.64%
More